Search for: "Mylan Inc." Results 181 - 200 of 674
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
Mylan Agrees to Settle FCA Lawsuit Regarding EpiPen
20 Aug 2017, 7:14 am by Gregory J. Brod
Pharmaceutical companies Mylan Inc. and Mylan Specialty L.P. agree to pay $465 million to settle a lawsuit brought under the False Claims Act (FCA). [read post]
Healthcare Fraud Lawyer Blog - https://www.healthcare-fraud-lawyer.com/
$465 Million Settlement in Our Client’s Qui Tam Whistleblower Case Over Pharmaceutical Manufacturer’s Underpaying Medicaid Rebates for New EpiPen Products
18 Aug 2017, 2:15 pm by Michael Sullivan
Mylan Inc., et al.. [read post]
Whistleblower Lawyer Blog - http://www.whistleblowerlawyerblog.com/
$465 Million Settlement in Our Client’s Qui Tam Whistleblower Case Over Pharmaceutical Manufacturer’s Underpaying Medicaid Rebates for New EpiPen Products
18 Aug 2017, 2:15 pm by Finch McCranie, LLP
Mylan Inc., et al.. [read post]
Whistleblower Lawyer Blog - http://www.whistleblowerlawyerblog.com/
$465 Million Settlement in Our Client’s Qui Tam Whistleblower Case Over Pharmaceutical Manufacturer’s Underpaying Medicaid Rebates for New EpiPen Products
18 Aug 2017, 2:15 pm by Michael Sullivan
Mylan Inc., et al.. [read post]
Whistleblower Lawyer Blog - http://www.whistleblowerlawyerblog.com/
Breadth through Specificity: Supporting Alternative Embodiments with Multiple Examples in Patent Applications
21 Jul 2017, 8:15 am by Matthew Kinnier
Mylan, Inc and Skedco, Inc. v. [read post]
IPWatchdog - http://www.ipwatchdog.com/
MILLENNIUM PHARMACEUTICALS scores win at CAFC in '446 (Velcade® ) case; Judge Newman explicates obviousness
17 Jul 2017, 9:41 am by Lawrence B. Ebert
Par Pharm., Inc. v. [read post]
IPBiz - http://ipbiz.blogspot.com/
The CAFC works through a chemical doctrine of equivalents case in Mylan v. Aurobindo
21 May 2017, 5:39 pm by Lawrence B. Ebert
Sciele Pharma, Inc. v. [read post]
IPBiz - http://ipbiz.blogspot.com/
PTAB Life Sciences Report
14 May 2017, 9:55 pm by Patent Docs
Mylan Pharmaceuticals, Inc. v. [read post]
Patent Docs - http://www.patentdocs.org/
More on The Medicines Company v. Mylan, 2017 U.S. App. LEXIS 5947. Reverse doctrine of equivalents?
18 Apr 2017, 6:52 am by Lawrence B. Ebert
Mylan, 2017 U.S. [read post]
IPBiz - http://ipbiz.blogspot.com/
Novartis loses IPR appeal at CAFC in Torrent case
12 Apr 2017, 9:52 am by Lawrence B. Ebert
(collectively, Novartis).The Board instituted IPRs on all claims of the ’283 patentbased on petitions filed by Torrent PharmaceuticalsLimited, Apotex, Inc. and Mylan Pharmaceuticals Inc. [read post]
IPBiz - http://ipbiz.blogspot.com/
Generics Successful at Invalidating Novartis Gilenya Patent
12 Apr 2017, 8:44 am by Dennis Crouch
Torrent Pharma, Apotex, and Mylan (Fed. [read post]
Patently-O - http://patentlyo.com/patent
Federal Circuit limits breadth of claims based on definition in specification, prosecution history
12 Apr 2017, 4:15 am by John M. Rogitz
Mylan, Inc. (2015-1113, 2015-1151, and 2015-1181) that imports certain subject matter from the specification into the claims... [read post]
IPWatchdog - http://www.ipwatchdog.com/
The Medicines Company v. Mylan, Inc. (Fed. Cir. 2017)
9 Apr 2017, 9:59 pm by Patent Docs
Noonan -- The Federal Circuit returned to its consideration of the outcome in the District Court of The Medicines Company's ANDA litigation against Mylan and Bioniche Pharma over a proposed generic version of Medicines' bivalirudin drug (sold as Angiomax®), an anticoagulant used in heart surgery. [read post]
Patent Docs - http://www.patentdocs.org/
CAFC in Medicines v. Mylan. Claim term limited to the sole portion of the specification that adequately discloses term
6 Apr 2017, 1:35 pm by Lawrence B. Ebert
Mylan, Inc., No. 15-1113(Fed. [read post]
IPBiz - http://ipbiz.blogspot.com/
Supreme Court Update: Are Secondary Indicia of Invention Relevant to Eligibility?
8 Feb 2017, 3:09 am by Dennis Crouch
Alfonso Cioffi, No. 16-200 (holding prosecution history against the patentee) Civil Procedure – Personal Jurisdiction: Mylan Pharmaceuticals, et al. v. [read post]
Patently-O - http://patentlyo.com/patent
Cumberland Pharmaceuticals Inc. v. Mylan Institutional LLC (Fed. Cir. 2017)
31 Jan 2017, 8:55 pm by Patent Docs
§ 102(f), in Cumberland Pharmaceuticals Inc. v. [read post]
Patent Docs - http://www.patentdocs.org/
Mylan loses its argument that "FDA invented it"
26 Jan 2017, 9:23 am by Lawrence B. Ebert
Cir. 2013);Slip Track Sys., Inc. v. [read post]
IPBiz - http://ipbiz.blogspot.com/
Supreme Court 2017 – Patent Preview
16 Jan 2017, 5:44 pm by Dennis Crouch
Alfonso Cioffi, No. 16-200 (holding prosecution history against the patentee) Civil Procedure – Personal Jurisdiction: Mylan Pharmaceuticals, et al. v. [read post]
Patently-O - http://patentlyo.com/patent
PTAB institutes 6 IPRs challenging RESTASIS patents
21 Dec 2016, 7:18 am by Gene Quinn
Mylan Pharmaceutical Inc. says they expect PTAB decisions on the IPRs sometime during the fourth quarter of 2017. [read post]
Patent Law Practice Center - http://patentlawcenter.pli.edu
PTAB Life Sciences Report -- Part I
7 Dec 2016, 9:59 pm by Patent Docs
Mylan Pharmaceuticals Inc. v. [read post]
Patent Docs - http://www.patentdocs.org/